Aspen Pharmacare shares up 11% on Covid-19 vaccine deal with Johnson & Johnson
JSE-listed Aspen Pharmacare has struck a deal with US multinational Johnson & Johnson to commercially manufacture its vaccine candidate.
Johnson & Johnson’s “Ad26.COV2-S” vaccine is undergoing clinical trials.
Aspen Pharmacare will make the vaccines at an existing factory in Port Elizabeth if trials are successful and manufacturing terms are finalised.
The facility is capable of making 300 million vaccine doses per year.
Aspen Pharmacare’s share price was up 11.45% on Monday.
The Money Show’s Bruce Whitfield interviewed Stephen Saad, CEO at Aspen Pharmacare.
Johnson & Johnson’s is a $400 billion company… We’re well-positioned… The tech transfer – we’ve started the process…Stephen Saad, CEO - Aspen Pharmacare
Johnson & Johnson… we like their candidate. You only need one shot… and a fridge… They’ve got 60 000 people in their Phase-3 trial…Stephen Saad, CEO - Aspen Pharmacare
Johnson & Johnson promised universal access…Stephen Saad, CEO - Aspen Pharmacare
We’ll be ready to put a vaccine into the world by March or April next year…Stephen Saad, CEO - Aspen Pharmacare
Listen to the interview in the audio below.
Source : https://www.123rf.com/photo_53976118_little-happy-girl-get-an-injection-vaccination.html?term=vaccine%2Bsmile&vti=mpp4sbopzossai9spw-1-1
An economist expects China growth at 9.5%, US money-printing, rising metal prices and trade- and current-account surpluses in SA.Read More
Bruce Whitfield asks personal finance advisor Warren Ingram to explain in detail the new laws affecting provident funds.Read More
You can buy R1 (or even one cent) worth of shares. "The key to getting started is to get started," says Charles Savage.Read More
Need new wheels? WesBank’s Lebogang Goaaketse discusses a popular method for making repayments more affordable.Read More
Distressed properties on auction are going for a song. Bruce Whitfield interviews property economist Francois Viruly.Read More
"It’s mandatory for medical schemes to pay for for the Covid-19 vaccine," says Dr Ryan Noach, CEO at Discovery Health.Read More
Investors are getting ahead of themselves, warns Pieter Hundersmarck, a fund manager at Flagship Asset Management.Read More
Bruce Whitfield interviews Tinashe Ruzane of FlexClub, where you can choose from a variety of car subscriptions for a monthly fee.Read More
The Money Show’s Bruce Whitfield interviews Basil Sgourdos, CFO at Naspers.Read More
The Money Show’s Bruce Whitfield interviews Leon Lourens, CEO at Pepkor Holdings.Read More